<optgroup id="umio8"></optgroup>
<optgroup id="umio8"><div id="umio8"></div></optgroup>
<center id="umio8"></center>
<code id="umio8"><xmp id="umio8"><code id="umio8"></code><optgroup id="umio8"><div id="umio8"></div></optgroup>
<center id="umio8"></center>
<center id="umio8"><wbr id="umio8"></wbr></center>
<center id="umio8"><div id="umio8"></div></center>
<optgroup id="umio8"><div id="umio8"></div></optgroup>
<center id="umio8"><div id="umio8"></div></center>
<optgroup id="umio8"><wbr id="umio8"></wbr></optgroup>
<center id="umio8"><wbr id="umio8"></wbr></center>

Media Release


ORPHAN DRUG DESIGNATION GRANTED BY THE FDA FOR WSD0922
Wayshine Biopharm holding limited Announces ORPHAN DRUG DESIGNATION GRANTED By The FDA For WSD0922 IN GLIOMA (including GLIOBLASTOM
Release time:2019-07-26
April 12,2019 IND approval by FDA
Wayshine Biopharm has received IND approval from FDA about its innovative experimental medicine WSD0922, a First-in-Class CNS penetrable EGF
Release time:2019-04-16
Copyright ? 2018 Wayshine Biopharm International Ltd. Cayman
<optgroup id="umio8"></optgroup>
<optgroup id="umio8"><div id="umio8"></div></optgroup>
<center id="umio8"></center>
<code id="umio8"><xmp id="umio8"><code id="umio8"></code><optgroup id="umio8"><div id="umio8"></div></optgroup>
<center id="umio8"></center>
<center id="umio8"><wbr id="umio8"></wbr></center>
<center id="umio8"><div id="umio8"></div></center>
<optgroup id="umio8"><div id="umio8"></div></optgroup>
<center id="umio8"><div id="umio8"></div></center>
<optgroup id="umio8"><wbr id="umio8"></wbr></optgroup>
<center id="umio8"><wbr id="umio8"></wbr></center>
国产色诱视频在线播放丝袜_性中国另类BBwBBw_亚洲AV片手机在线观看_国自产精品手机在线视频